Since Its Inception In 1984The Timi Study Group Has Been An Academic Research Organization Dedicated To Advancing The Knowledge And Care Of Patients Suffering From Cardiovascular Diseasewe Have Led A Wide Array Of Trialsfrom Phase I To Phase Ivenrolling From Less Than 30 To More Than 26 000 Subjectsand With Both Industry And Nih Supporttrials Have Been Conducted In Over 50 Countries And At More Than 5000 Separate Sites We Investigate A Broad Array Of Therapeutic Interventions In Individuals Across The Spectrum Of Cardiovascular Diseaseranging From Prevention In Those With Risk Factorsto Emergent Interventions In Those With Acute Manifestations Of Diseasein Additionwe Have Used Our Large Database Of Clinical Findingsbiomarkersand Genotypes To Enhance The Understanding Of Cardiovascular Disease And Its Risk Factors By Leading Large Scaleinternationalrandomized Controlled Trials Of Novel Therapeutics And Performing Sophisticated Analyseswe Have Been Privileged To Help Shape The Very Practice Of Cardiovascular Medicine For Over A Quarter Of A Century
